SolasCure

SolasCure is a biotechnology company. The company offers Aurase Wound Gel, a hydrogel containing enzymes cloned from medical maggots, designed to accelerate wound debridement. It will proceed to further Phase II efficacy-supporting trials. Compared to the Phase IIa safety study, the next stage of trials will include a larger and more diverse patient population. The company hopes these results will continue to demonstrate how its innovative technology can support healthcare professionals in treating patients with chronic wounds.